Clinical Trial Update: Temozolomide vs. Temozolomide and Thalidomide Treatment in Recurrent Glioblastoma [Phase 2]

View source ↗

Summary

Clinical trial update for a Phase 2 study comparing temozolomide alone versus temozolomide with thalidomide in recurrent glioblastoma. The current status is UNK…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Temozolomide (Temozolomide)
• Thalidomide (thalidomide)

Snippet

Sponsor: University of Zurich | Conditions: Glioblastoma | Phase 2 | Status: UNKNOWN